A Pharmacist Consultation Service in Community-Based Family Practices: A Randomized, Controlled Trial in Seniors
| Autor: | Michelle Howard, John W. Sellors, Janusz Kaczorowski, Connie Sellors, Dawn M. Dalby |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Community based
Medication use medicine.medical_specialty business.industry Pharmacist Pharmaceutical Science 030204 cardiovascular system & hematology 030226 pharmacology & pharmacy law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Family medicine Patient Participation Rates Physical therapy Medicine business Drug regimen |
| Zdroj: | Journal of Pharmacy Technology. 17:264-269 |
| ISSN: | 1549-4810 8755-1225 |
| DOI: | 10.1177/875512250101700604 |
| Popis: | Objective: To conduct a pilot study for a larger randomized trial investigating the efficacy and cost-effectiveness of a pharmacist consultation (PC) program for elderly patients in family practice. Design: Randomized, observer-blinded, controlled trial with two patient groups: PC and control. The study pharmacist interviewed each PC program participant in their physician's office, prepared a letter, and reviewed the drug regimen recommendations in the letter with the physician. The number and types of recommendations made, the proportion of the pharmacist's recommendations implemented by physicians, and daily medication use and costs at the end of six months are reported. Setting: One hundred thirty-two patients aged 65 years and older from four family practices in Stoney Creek, Ontario, Canada, who regularly were taking four or more medications. Results: Patient participation rates demonstrated feasibility: 191 patients were eligible, with 132 (69.1%) of these consenting to be enrolled. A mean ± SD of 3.0 ± 1.7 recommendations per patient were made for 62 (93.9%) of 66 patients in the PC group, and 77.8% (119/153) of these recommendations were implemented or partially implemented by the physicians. After six months, the mean numbers of medication units were 14.7 ± 10.8 and 13.9 ± 8.2, p = 0.66. The mean daily medication costs were $2.73 ± 1.78 and $2.47 ± 1.78, p = 0.43 in the control and PC groups, respectively. Conclusions: This pilot study demonstrated the need, the feasibility, and the potential effects of the PC program. The results were used to design a larger trial in which physicians rather than patients were randomized to further evaluate the program. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|